Results 121 to 130 of about 11,360 (208)

A systematic review of lumefantrine

Annals of Phytomedicine An International Journal, 2023
P. Shanmugasundaram, S. Harshini, G. Nithish Kumar   +2 more
openaire   +1 more source

Molecular surveillance of antimalarial drug resistance markers in the pfcrt, pfmdr1 and pfmrp1 genes of Plasmodium falciparum isolates from southeastern Iran. [PDF]

Malar J
Jafari M, Rezapour R, Nemati F, Mehrizi AA, Pirahmadi S.   +4 more
europepmc   +1 more source

Recurrent parasitemias with artemisinin partial resistance mutations during the 2024 Ethiopia malaria resurgence: a case series. [PDF]

Malar J
Geleta D, Brhane BG, Abera A, Belachew M, Sime H, Gebreegziaxher A, Getu M, Ali A, Tesfay N, Habtetsion M, Kokobe B, Kebede M, Worku Z, Tasew G, Tadesse G, Tollera G, Fola AA, Bailey JA, Juliano JJ, Parr JB, Abte M, Assefa A.   +21 more
europepmc   +1 more source

Resurgence of Malaria in Ethiopia. [PDF]

JAMA
Assefa A, Brhane BG, Gerdes Gyuricza I, Sime H, Belachew M, Hailu Dangisso M, Tollera G, Bailey JA, Juliano JJ, Fola AA, Tasew G, Parr JB, Malaria Resurgence Investigation Group.   +12 more
europepmc   +1 more source

Border Region Surveillance of Malaria Drug Resistance, Northern Burundi, 2023-2024. [PDF]

Emerg Infect Dis
Niyomwungere D, Sinarinzi P, Caspar E, Thiebaut L, Strubel PE, Tibiri YNG, Ma L, Rurihafi J, Ndizeyimana P, Hakizimana P, Niyizompa N, Witonze A, Ndayiragije V, Ndayisenga F, Ndikumukiza M, Niyonkuru O, Niyonsaba JC, Bangirinama C, Bigirimana JL, Ntahondi N, Mugisha L, Nibakire M, Nzoyikorera N, Sinzinkayo D, Menard D, Nyandwi J.   +25 more
europepmc   +1 more source

Novel <i>Pfk13</i> and <i>Pfubp1</i> genotypes in African <i>Plasmodium falciparum</i> isolates exhibiting reduced susceptibility to the antimalarials artemisinin and lumefantrine. [PDF]

mBio
Pratt S, van Schalkwyk DA, Stewart L, Hocke EF, Mannan S, Berry C, Muwanguzi-Karugaba J, Nolder D, Rogers C, Chiodini PL, Henrici RC, Moss S, Billows N, Phelan J, Clark TG, Campino S, Sutherland CJ.   +16 more
europepmc   +1 more source

Impact of Dolutegravir-, Lopinavir/Ritonavir-, and Efavirenz-Based Antiretrovirals on Piperaquine Pharmacokinetics in Ugandan Children Living with HIV. [PDF]

Clin Pharmacol Ther
Kajubi R, Koire M, Whalen ME, Orukan F, Okiring J, Marzan F, Richards K, Lier AJ, Goodwin J, Colt M, Pham X, He S, Chu DHT, Opira B, Kisitu GP, Sekabira R, Kekitiinwa A, Huynh D, Khoury M, Gallison K, Fotaki N, Mwima MW, Kamya MR, Aweeka FT, Parikh S, Huang L, Mwebaza N.   +26 more
europepmc   +1 more source

Transplacental Transfer of Lumefantrine, Mefloquine, and Piperaquine: A Comparison of Concentrations in Mothers, Neonates, and Cord Blood. [PDF]

Clin Infect Dis
Saito M, Gilder ME, Carrara VI, Archusuksan L, Eh H, Eh N, Ner M, Win AK, Niwetphongprai L, Koesukwiwat U, Tarning J, White NJ, Nosten F, McGready R.   +13 more
europepmc   +1 more source

Efficacy and safety of artemether-lumefantrine (AL) and artesunate-amodiaquine (ASAQ) for the treatment of uncomplicated Plasmodium falciparum malaria among children 6-59 months in three sentinel sites of Sierra Leone, 2021-2022. [PDF]

Malar J
Cavros I, Abanyie F, Kamara ARY, Chalobah F, Fofana N, Ahmed J, Larbi K, Kennedy C, Horton B, Bajic M, Richardson M, Matlock B, McCaffery J, Kanu S, Schnabel D, Labor TSA, Cash S, Plucinski M, Komeh JP, Sillah-Kanu M.   +19 more
europepmc   +1 more source

Gaps in knowledge and use of artemether-lumefantrine among university students in Southwestern Nigeria: A cross-sectional study. [PDF]

PLoS One
Orok E, Olumoko O, Ekada I, Oladunni A.
europepmc   +1 more source